Obese Patients Have Inadequate Protein Intake Related to Protein Intolerance Up to 1 Year Following Roux-en-Y Gastric Bypass
Overview
Authors
Affiliations
Background: Inadequate protein intake is a concern following Roux-en-Y gastric bypass (RYGBP). The small gastric pouch and bypass restrict energy intake and may lead to insufficient protein intake and absorption, and excess loss of lean tissue.
Methods: We evaluated protein intake in 93 (77 F, 16 M) morbidly obese individuals (BMI = 52.0 +/- 12.9 [SD]) who underwent RYGBP at our medical center. Participants completed 24-hr food recalls and received nutritional counseling at 3, 6, and 12 months following surgery.
Results: Daily energy intake (kcal/day) increased from 849 +/- 329 (SD) at 3 months to 1,101 +/- 400 at 12 months (P = .009). Protein intake also increased (g/day) from 45.6 +/- 14.2 at 3 months to 58.5 +/- 17.1 at 12 months (P = .04), and as a percentage of goal protein intake from 55.1% +/- 23.0 at 3 months to 73.5% +/- 38.0 at 12 months (P = .02). Although energy and protein intake increased significantly over the 12-month period, protein intake at 12 months remained significantly lower (P = .01) than the daily recommended guidelines (1.5 g/kg IBW) for a low-energy restrictive diet. Energy intake did not differ in those who reported food intolerances at 3 months (P = .77) or 6 months (P = .65), but was lower in them at 12 months (trend, P = .06). Also at 12 months, protein intake (P = .02) and percentage of protein intake goal (P = .04) were significantly lower in those with protein intolerance.
Conclusions: These results suggest that postoperative patients consume insufficient amounts of protein, possibly mediated by protein intolerance. Protein supplementation following RYGBP deserves further consideration.
Protein supplementation preserves muscle mass in persons against sleeve gastrectomy.
Afsar N, Ozdogan Y Front Nutr. 2024; 11:1476258.
PMID: 39444573 PMC: 11496275. DOI: 10.3389/fnut.2024.1476258.
Protein Supplement Tolerability and Patient Satisfaction after Bariatric Surgery.
Luijpers C, Nuijten M, Groenhuijzen E, van Hogezand L, Monpellier V, Eijsvogels T Obes Surg. 2024; 34(10):3866-3875.
PMID: 39243332 PMC: 11481670. DOI: 10.1007/s11695-024-07462-4.
Qanaq D, OKeeffe M, Cremona S, Bernardo W, McIntyre R, Papada E Obes Surg. 2024; 34(8):3021-3037.
PMID: 38907132 PMC: 11289176. DOI: 10.1007/s11695-024-07183-8.
Zhan D, Long Z, Yang H, Wang H, He C, Yin J Obes Surg. 2024; 34(5):1608-1617.
PMID: 38530552 DOI: 10.1007/s11695-024-07157-w.
Carpentieri G, Goncalves S, Mourad W, Pinto L, Zanella M Arch Endocrinol Metab. 2023; 67(3):442-449.
PMID: 36748934 PMC: 10247255. DOI: 10.20945/2359-3997000000598.